Rethinking Perfusion Imaging for Oncology Assessment in Brain
Duration: 25 min
Using perfusion imaging for assessing brain tumors can be complicated as the imaging may suffer from artifacts and require manual steps while providing only limited information on tissue status in brain tumors.
In this webinar Professor Kim Beuschau Mouridsen gives an introduction to a new approach to perfusion imaging that allows to get unique insights into brain tissue oxygenation for reliable tumor grading and prognosis while using your existing imaging protocols.
Kim Beuschau Mouridsen, Founder and Managing Director at Cercare Medical, Professor at Aarhus University
Kim Mouridsen, PhD, MSc is a Professor at Aarhus University. He is the head of Neuroimaging Methods at the Center for Functionally Integrative Neuroscience (CFIN) and MINDLab. Professor Mouridsen has published over 40 papers in peer-reviewed journals including Nature Medicine and holds 6 patent applications.
About Cercare Medical
Founded in 2013 as a spin-out from Aarhus University, Denmark, Cercare Medical puts its focus on bringing clinical research to life with breakthrough technology. Our goal is to deliver unparalleled image quality and simpler workflows. Our current CE-marked portfolio, grounded in more than 15 years of research in perfusion imaging, consists of imaging solutions for a wide range of neurological disorders, including oncology and stroke.